2023 Q4 Form 10-K Financial Statement
#000095017024033902 Filed on March 20, 2024
Income Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $631.0K | $2.037M |
YoY Change | 53.44% | 24.89% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $631.0K | $2.037M |
YoY Change | 53.44% | 24.89% |
Operating Profit | -$2.037M | |
YoY Change | 24.89% | |
Interest Expense | $7.310M | $26.43M |
YoY Change | 64.79% | 249.38% |
% of Operating Profit | ||
Other Income/Expense, Net | $2.067M | $1.808M |
YoY Change | -50.0% | -83.18% |
Pretax Income | $8.745M | $26.20M |
YoY Change | 7.2% | 57.04% |
Income Tax | $761.8K | $2.951M |
% Of Pretax Income | 8.71% | 11.27% |
Net Earnings | $7.984M | $23.25M |
YoY Change | 5.35% | 44.83% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.12 | $0.35 |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.843M | $1.843M |
YoY Change | 387.35% | 387.35% |
Cash & Equivalents | $0.00 | |
Short-Term Investments | ||
Other Short-Term Assets | $25.19K | $25.19K |
YoY Change | -97.33% | -97.33% |
Inventory | ||
Prepaid Expenses | $25.19K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $1.868M | $1.868M |
YoY Change | 41.22% | 41.22% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $555.5M | $555.5M |
YoY Change | 4.44% | 4.44% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $555.5M | $555.5M |
YoY Change | 4.44% | 4.44% |
TOTAL ASSETS | ||
Total Short-Term Assets | $1.868M | $1.868M |
Total Long-Term Assets | $555.5M | $555.5M |
Total Assets | $557.4M | $557.4M |
YoY Change | 4.53% | 4.53% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $400.9K | $400.9K |
YoY Change | 76.25% | 76.25% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $650.0K | $650.0K |
YoY Change | 8.33% | 8.33% |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $3.648M | $3.648M |
YoY Change | 284.32% | 284.32% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $3.100M | $3.100M |
YoY Change | -36.84% | -36.84% |
Total Long-Term Liabilities | $3.100M | $3.100M |
YoY Change | -36.84% | -36.84% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $3.648M | $3.648M |
Total Long-Term Liabilities | $3.100M | $3.100M |
Total Liabilities | $25.64M | $25.64M |
YoY Change | 3.63% | 3.63% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$22.72M | |
YoY Change | 0.88% | |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$22.71M | $531.8M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $557.4M | $557.4M |
YoY Change | 4.53% | 4.53% |
Cashflow Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $7.984M | $23.25M |
YoY Change | 5.35% | 44.83% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$1.051M | -$1.411M |
YoY Change | 1028.96% | -43.85% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $2.826M | $2.826M |
YoY Change | -100.54% | |
Cash From Investing Activities | $2.826M | $2.826M |
YoY Change | -100.54% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 50.00K | 50.00K |
YoY Change | -99.99% | |
NET CHANGE | ||
Cash From Operating Activities | -1.051M | -1.411M |
Cash From Investing Activities | 2.826M | 2.826M |
Cash From Financing Activities | 50.00K | 50.00K |
Net Change In Cash | 1.824M | 1.464M |
YoY Change | -2058.85% | 534.2% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.051M | -$1.411M |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001894630 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2023 | ghix |
Threshold Number Of Period To Seek Shareholders Approval Prior To Consummation Of Business Combination To Redeem Their Shares
ThresholdNumberOfPeriodToSeekShareholdersApprovalPriorToConsummationOfBusinessCombinationToRedeemTheirShares
|
P2D | |
CY2023 | ghix |
Threshold Number Of Period To Provide Opportunity To Shareholders To Sell Their Shares Prior To Consummation Of Business Combination
ThresholdNumberOfPeriodToProvideOpportunityToShareholdersToSellTheirSharesPriorToConsummationOfBusinessCombination
|
P2D | |
CY2023 | ghix |
Number Of Possible Days For Winding Up
NumberOfPossibleDaysForWindingUp
|
P10D | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-41215 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
GORES HOLDINGS IX, INC. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-1593799 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
6260 Lookout Road | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Boulder | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CO | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
80301 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
303 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
531-3100 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
538130000 | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
100 | |
CY2023 | dei |
Auditor Name
AuditorName
|
WithumSmith+Brown, PC | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
New York, New York, USA | |
CY2023Q4 | us-gaap |
Cash
Cash
|
1842524 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
378072 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
25186 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
944461 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1867710 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1322533 | |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
555541639 | |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
531940494 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
557409349 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
533263027 | |
CY2023Q4 | ghix |
Accrued Expenses Formation And Offering Costs
AccruedExpensesFormationAndOfferingCosts
|
360875 | |
CY2022Q4 | ghix |
Accrued Expenses Formation And Offering Costs
AccruedExpensesFormationAndOfferingCosts
|
27446 | |
CY2023Q4 | ghix |
Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
|
40000 | |
CY2022Q4 | ghix |
Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
|
200000 | |
CY2023Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
2596715 | |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
121667 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3647590 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
949113 | |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
518136 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
509185 | |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
18375000 | |
CY2022Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
18375000 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
25640726 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
24741631 | |
CY2023Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
52500000 | |
CY2022Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
52500000 | |
CY2023Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.56 | |
CY2022Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.12 | |
CY2023Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10 | |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
554482346 | |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
531037712 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22715036 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22517629 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22713723 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22516316 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
557409349 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
533263027 | |
CY2023 | ghix |
Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
|
1836585 | |
CY2022 | ghix |
Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
|
1430672 | |
CY2023 | us-gaap |
Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
|
200000 | |
CY2022 | us-gaap |
Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
|
200000 | |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2036585 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1630672 | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1808333 | |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-11366667 | |
CY2022 | ghix |
Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
|
617225 | |
CY2023 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
26426823 | |
CY2022 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
7564018 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
26198571 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
16682788 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2951344 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
630852 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23247227 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
16051936 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22516316 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23247227 | |
CY2023 | ghix |
Increase In Redemption Value Of Common Stock Subject To Redemption
IncreaseInRedemptionValueOfCommonStockSubjectToRedemption
|
-23444634 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22713723 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
18888 | |
CY2022 | ghix |
Adjustments To Additional Paid In Capital Excess Of Fair Value Paid By Founders For Warrants
AdjustmentsToAdditionalPaidInCapitalExcessOfFairValuePaidByFoundersForWarrants
|
7250000 | |
CY2022 | ghix |
Adjustments To Additional Paid In Capital For Subsequent Measurement Of Common Stock Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalForSubsequentMeasurementOfCommonStockSubjectToRedemption
|
7273688 | |
CY2022 | ghix |
Subsequent Measurement Of Common Stock Subject To Redemption Against Accumulated Deficit
SubsequentMeasurementOfCommonStockSubjectToRedemptionAgainstAccumulatedDeficit
|
32525740 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
16051936 | |
CY2022 | ghix |
Increase In Redemption Value Of Common Stock Subject To Redemption
IncreaseInRedemptionValueOfCommonStockSubjectToRedemption
|
-6037712 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22516316 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
23247227 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
16051936 | |
CY2022 | ghix |
Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
|
617225 | |
CY2023 | ghix |
Dividends Reinvested In Trust Account
DividendsReinvestedInTrustAccount
|
26426822 | |
CY2022 | ghix |
Dividends Reinvested In Trust Account
DividendsReinvestedInTrustAccount
|
7564018 | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1808333 | |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-11366667 | |
CY2023 | ghix |
Increase Decrease In Accrual For State Franchise Taxes Current
IncreaseDecreaseInAccrualForStateFranchiseTaxesCurrent
|
-160000 | |
CY2022 | ghix |
Increase Decrease In Accrual For State Franchise Taxes Current
IncreaseDecreaseInAccrualForStateFranchiseTaxesCurrent
|
195930 | |
CY2023 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
2475048 | |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
121667 | |
CY2023 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-8951 | |
CY2022 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-509185 | |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-919275 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
944461 | |
CY2023 | ghix |
Increase Decrease In Accrued Expenses Formation And Offering Costs Current
IncreaseDecreaseInAccruedExpensesFormationAndOfferingCostsCurrent
|
333429 | |
CY2022 | ghix |
Increase Decrease In Accrued Expenses Formation And Offering Costs Current
IncreaseDecreaseInAccruedExpensesFormationAndOfferingCostsCurrent
|
-134300 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1411225 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2513503 | |
CY2022 | ghix |
Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
|
525000000 | |
CY2023 | ghix |
Cash Withdrawn From Trust Account For Tax And Regulatory Expenses
CashWithdrawnFromTrustAccountForTaxAndRegulatoryExpenses
|
2825677 | |
CY2022 | ghix |
Cash Withdrawn From Trust Account For Tax And Regulatory Expenses
CashWithdrawnFromTrustAccountForTaxAndRegulatoryExpenses
|
623524 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2825677 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-524376476 | |
CY2022 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
525000000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
12500000 | |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
650000 | |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
600000 | |
CY2023 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
600000 | |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
300000 | |
CY2022 | ghix |
Payment Of Underwriters Discounts And Commissions
PaymentOfUnderwritersDiscountsAndCommissions
|
10500000 | |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
179109 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
50000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
527120891 | |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1464452 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
230912 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
378072 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
147160 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1842524 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
378072 | |
CY2022 | ghix |
Offering Costs Included In Accrued Expenses Formation And Offering Costs
OfferingCostsIncludedInAccruedExpensesFormationAndOfferingCosts
|
337544 | |
CY2022 | ghix |
Deferred Underwriting Compensation
DeferredUnderwritingCompensation
|
18375000 | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
50350 | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
4070 | |
CY2023 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. Organization and Business Operations</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Organization and General</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Gores Holdings IX, Inc. (the “Company”) was incorporated in Delaware on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 19, 2021</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has neither engaged in any operations nor generated any revenue to date. The Company’s management has broad discretion with respect to the Business Combination. The Company’s Sponsor is Gores Sponsor IX, LLC, a Delaware limited liability company (the “Sponsor”). The Company has selected December 31st as its fiscal year-end.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At December 31, 2023, the Company had not commenced any operations. All activity for the Period from January 19, 2021 (inception) through January 13, 2022 relates to the Company’s formation and initial public offering (“Public Offering”) described below. The Company subsequently completed the Public Offering on January 14, 2022 (the “IPO Closing Date”). The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. Subsequent to the Public Offering, the Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financing</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Upon the IPO Closing Date and the sale of the Private Placement Warrants, an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">525,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> was placed in a Trust Account with Deutsche Bank Trust Company Americas (the “Trust Account”) acting as Trustee.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company intends to finance a Business Combination with the net proceeds from its $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">525,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Public Offering and its sale of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of Private Placement Warrants, less redemptions exercised in January 2024.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Trust Account</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Funds held in the Trust Account can be invested only in U.S. government treasury bills or money market with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under Rule 2a‑7 under the Investment Company Act that invest only in direct U.S. government obligations. As of December 31, 2023 and December 31, 2022, the Trust Account consisted of money market funds.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s second amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund regulatory compliance requirements and other costs related thereto (a “Regulatory Withdrawal”) by December 6, 2024 (or such earlier date as determined by the Company's board of directors) and/or additional amounts necessary to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i) the completion of the Business Combination; or (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of such public shares of common stock if the Company does not complete the Business Combination by December 6, 2024 (or such earlier date as determined by the Company's board of directors) from the closing of the Public Offering; or (iii) the redemption of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the public shares of common stock if the Company is unable to complete a Business Combination by December 6, 2024 (or such earlier date as determined by the Company's board of directors) from the closing of the Public Offering, subject to the requirements of law and stock exchange rules.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Combination</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_d33db985-9de9-4637-8a98-3244ba20fd52;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">two</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> business days prior to the consummation of the Business Combination, including interest income but less taxes payable, or (ii) provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6c4d03d5-ccc6-4d60-b323-fda4abb6e802;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">two</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> business days prior to the consummation of the Business Combination, including interest income but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under Nasdaq rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. Currently, the Company will not redeem its public shares of common stock in an amount that would cause its net tangible assets to be less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,000,001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a result of the foregoing redemption provisions, the public shares of common stock will be recorded at redemption amount and classified as temporary equity, in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”) in subsequent periods.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company will have until December 6, 2024 (or such earlier date as determined by the Company's board of directors) from the IPO Closing Date to complete its Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a59004c6-803d-4f9f-b4bf-d8cacfc37810;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> business days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of such net interest income to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire public shares of common stock, they will be entitled to a pro rata share of the Trust Account in the event the Company does not complete a Business Combination within the required time period.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Emerging Growth Company</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 102(b)(1) of the Jumpstart Our Business Startup (“JOBS”) Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</span></p> | |
CY2023 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2021-01-19 | |
CY2022Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
525000000 | |
CY2023Q4 | ghix |
Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
|
1 | |
CY2023Q4 | ghix |
Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
|
1 | |
CY2023 | ghix |
Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
|
100000 | |
CY2023 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
2862562 | |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
121667 | |
CY2023 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
79831 | |
CY2023Q4 | ghix |
Working Capital Deficit
WorkingCapitalDeficit
|
-1779880 | |
CY2022Q4 | ghix |
Working Capital Deficit
WorkingCapitalDeficit
|
373420 | |
CY2022Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
525000000 | |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which throughout the year regularly exceed the Federal Deposit Insurance Corporation coverage limit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</span></p> | |
CY2023Q4 | us-gaap |
Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
|
250000 | |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
29391653 | |
CY2023 | ghix |
Underwriters Fee
UnderwritersFee
|
28875000 | |
CY2022 | ghix |
Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
|
617225 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</span></p> | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | |
CY2023Q4 | ghix |
Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
|
1 | |
CY2023Q4 | ghix |
Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
|
1 | |
CY2022Q4 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
531940494 | |
CY2023Q4 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
555541639 | |
CY2023 | ghix |
Going Concern Description
GoingConcernDescription
|
In connection with an assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” the Company has until December 6, 2024 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If the Company does not complete its Business Combination by December 6, 2024, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the common stock sold as part of the units in the Public Offering, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of franchise and income taxes payable and less up to $100,000 of such net interest which may be distributed to the Company to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. | |
CY2023 | ghix |
Common Stock Redemption Percentage
CommonStockRedemptionPercentage
|
1 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3647590 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
949113 | |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
5507401 | |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
3503385 | |
CY2023 | ghix |
Income Tax Reconciliation Warrant Liability
IncomeTaxReconciliationWarrantLiability
|
379750 | |
CY2022 | ghix |
Income Tax Reconciliation Warrant Liability
IncomeTaxReconciliationWarrantLiability
|
2387000 | |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-10351 | |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
2311 | |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
129617 | |
CY2023 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
2595094 | |
CY2022 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
615965 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Cash To Accrual True Up Amount
EffectiveIncomeTaxRateReconciliationCashToAccrualTrueUpAmount
|
429137 | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-1496 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2951344 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
630852 | |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
2942393 | |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
121667 | |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-62535 | |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
507087 | |
CY2023 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
71486 | |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
2098 | |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
8951 | |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
509185 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2951344 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
630852 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
91473 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
55670 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
81837 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
91473 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
137507 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
91473 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
137507 | |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
6164 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
231166 | |
CY2023Q4 | ghix |
Deferred Tax Liabilities Accrued Income
DeferredTaxLiabilitiesAccruedIncome
|
603445 | |
CY2022Q4 | ghix |
Deferred Tax Liabilities Accrued Income
DeferredTaxLiabilitiesAccruedIncome
|
415526 | |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
609609 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
646692 | |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
518136 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
509185 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Facilitative Expenses Percent
EffectiveIncomeTaxRateReconciliationFacilitativeExpensesPercent
|
0.000 | |
CY2022 | ghix |
Effective Income Tax Rate Reconciliation Facilitative Expenses Percent
EffectiveIncomeTaxRateReconciliationFacilitativeExpensesPercent
|
0.000 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Fed Deduction For State Taxes Paid Percent
EffectiveIncomeTaxRateReconciliationFedDeductionForStateTaxesPaidPercent
|
0 | |
CY2022 | ghix |
Effective Income Tax Rate Reconciliation Fed Deduction For State Taxes Paid Percent
EffectiveIncomeTaxRateReconciliationFedDeductionForStateTaxesPaidPercent
|
0 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.008 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Penalty Percent
EffectiveIncomeTaxRateReconciliationPenaltyPercent
|
0 | |
CY2022 | ghix |
Effective Income Tax Rate Reconciliation Penalty Percent
EffectiveIncomeTaxRateReconciliationPenaltyPercent
|
0 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Contingencies State And Local
EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal
|
0 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Contingencies State And Local
EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal
|
0 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0.016 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
|
0.014 | |
CY2022 | ghix |
Effective Income Tax Rate Reconciliation Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
|
0.143 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
0.099 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
0.037 | |
CY2023 | ghix |
Effective Income Tax Rate Reconciliation Change In State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInStateTaxRatePercent
|
0.000 | |
CY2022 | ghix |
Effective Income Tax Rate Reconciliation Change In State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInStateTaxRatePercent
|
0.000 | |
CY2023 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.113 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.038 | |
CY2023 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Holders of the Company’s common stock are entitled to one vote for each share of common stock. | |
CY2023Q4 | ghix |
Number Of Votes For Each Share
NumberOfVotesForEachShare
|
1 | |
CY2023Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
52500000 | |
CY2022Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
52500000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023 | us-gaap |
Preferred Stock Voting Rights
PreferredStockVotingRights
|
with such designations, voting and other rights and preferences as may be determined from time to time by the Company's board of directors. | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |